JB

Jayvijaysinh Bhursinh Parmar

Active Director Director DIN 08966561
DIN 08966561 First appointment Nov 2020 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayvijaysinh Bhursinh Parmar

Data last updated:

Jayvijaysinh Bhursinh Parmar is a Director at Revamani Medical College And Hospital Limited (since 2020). The company operates in Healthcare.

DIN 08966561
Primary Designation Director
Industry Healthcare
First Appointment 10 Nov 2020
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Nov 20202015Active

Board colleagues of Jayvijaysinh Bhursinh Parmar

Directorship timeline

Open interactive timeline →
Revamani Medical College And Hospital Limited
Premium access

Shareholding and investment profile for Jayvijaysinh Bhursinh Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayvijaysinh Bhursinh Parmar

Jayvijaysinh Bhursinh Parmar currently holds 1 directorship: Revamani Medical College And Hospital Limited (Director, since 10 Nov 2020).

Jayvijaysinh Bhursinh Parmar was first appointed on 10 Nov 2020 as Director at Revamani Medical College And Hospital Limited.

The current boards of Jayvijaysinh Bhursinh Parmar's companies include Ashokkumar Kanjibhai Chaudhari (Revamani Medical College And Hospital Limited), Shantilal Manilal Patel (Revamani Medical College And Hospital Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available